Patents by Inventor Matt Gregory

Matt Gregory has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS
    Publication number: 20240033320
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: December 14, 2022
    Publication date: February 1, 2024
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • ENZYMATIC METHODS FOR CONVERTING LCA AND 3-KCA TO UDCA AND 3-KUDCA
    Publication number: 20230416800
    Abstract: 7?-hydroxylation systems are provided, as well as methods for producing ?P-hydroxy derivatives of lithocholic acid and 3-keto-lithocholic acid from such systems. Also provided are recombinant organisms useful for the production of such enzymatic systems, and to plasmids that encode for such enzymes.
    Type: Application
    Filed: November 29, 2021
    Publication date: December 28, 2023
    Inventors: J. GREGORY REID, JAYACHANDRA P. REDDY, MATT GREGORY, URSULA SCHELL, BERNHARD J. PAUL
  • NOVEL COMPOUNDS (IMMUNORHELINS)
    Publication number: 20230118205
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Application
    Filed: August 16, 2022
    Publication date: April 20, 2023
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immunorhelin compounds for intracellular infections
    Patent number: 11564969
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: January 31, 2023
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (publ)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Compounds (immunorhelins)
    Patent number: 11434258
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 6, 2022
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Use of known compounds—intracellular infections
    Patent number: 11304990
    Abstract: The present invention provides a method of treating intracellular infections, in particular intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: April 19, 2022
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immune stimulating macrolides
    Patent number: 11059845
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in claim 1. The macrolides have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immune stimulating compound
    Patent number: 11059846
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immune stimulating macrolides
    Patent number: 11059844
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in the claims. The macrolides have utility in treating viral diseases and cancer.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immune stimulating macrolide
    Patent number: 10919927
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating viral diseases and cancer.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: February 16, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Robert Wallin, Emma Lindh, Matt Gregory, Steven Moss
  • NOVEL IMMUNE STIMULATING MACROLIDES
    Publication number: 20200010498
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in the claims. The macrolides have utility in treating viral diseases and cancer.
    Type: Application
    Filed: February 22, 2018
    Publication date: January 9, 2020
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL IMMUNE STIMULATING COMPOUND
    Publication number: 20200010499
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: February 22, 2018
    Publication date: January 9, 2020
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL IMMUNE STIMULATING MACROLIDES
    Publication number: 20190389896
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in claim 1. The macrolides have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: February 22, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL COMPOUNDS (IMMUNORHELINS - INTRACELLULAR INFECTIONS)
    Publication number: 20190388497
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL COMPOUNDS (IMMUNORHELINS)
    Publication number: 20190389908
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL USE OF KNOWN COMPOUNDS - INTRACELLULAR INFECTIONS
    Publication number: 20190374598
    Abstract: The present invention provides a method of treating intracellular infections, in particular intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 12, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL IMMUNE STIMULATING MACROLIDE
    Publication number: 20190367551
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating viral diseases and cancer.
    Type: Application
    Filed: February 22, 2018
    Publication date: December 5, 2019
    Inventors: Ola Winqvist, Robert Wallin, Emma Lindh, Matt Gregory, Steven Moss